135 related articles for article (PubMed ID: 38367167)
1. Bacteriological and molecular study of fosfomycin resistance in uropathogenic Escherichia coli.
Ibrahim AA; Mohammed RK
Braz J Microbiol; 2024 Jun; 55(2):1091-1097. PubMed ID: 38367167
[TBL] [Abstract][Full Text] [Related]
2. High incidence of fosfomycin-resistant uropathogenic E. coli among children.
Abdelraheem WM; Mahdi WKM; Abuelela IS; Hassuna NA
BMC Infect Dis; 2023 Jul; 23(1):475. PubMed ID: 37460976
[TBL] [Abstract][Full Text] [Related]
3. Significant association between genes encoding virulence factors with antibiotic resistance and phylogenetic groups in community acquired uropathogenic Escherichia coli isolates.
Yazdanpour Z; Tadjrobehkar O; Shahkhah M
BMC Microbiol; 2020 Aug; 20(1):241. PubMed ID: 32758126
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
Bi W; Li B; Song J; Hong Y; Zhang X; Liu H; Lu H; Zhou T; Cao J
Int J Antimicrob Agents; 2017 Jul; 50(1):29-34. PubMed ID: 28456703
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of adhesin genes and risk factors associated with urinary tract infections by drug-resistant uropathogenic Escherichia coli in North of Iran.
Sheikhi R; Amini ME; Alidoust L; Atrkar Roushan Z; Nikokar I
J Infect Dev Ctries; 2024 May; 18(5):761-769. PubMed ID: 38865401
[TBL] [Abstract][Full Text] [Related]
6. Study of class 1 integrons and plasmid profile among multiple drug resistant uropathogenic Escherichia coli.
Javed S; Mirani ZA; Pirzada ZA
Pak J Pharm Sci; 2020 Nov; 33(6):2643-2649. PubMed ID: 33867342
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Antimicrobial Activity of Eugenol in Combination with Fosfomycin to Combat Escherichia coli and Potential Effect on Plasmid-Mediated Fosfomycin Resistance Genes.
Attaallah Ibrahim A; Kadhim Mohammed R
Chem Biodivers; 2023 Dec; 20(12):e202301567. PubMed ID: 37956152
[TBL] [Abstract][Full Text] [Related]
8. Fosfomycin use in multi drug resistant uropathogenic Escherichia coli.
Mittal S; Sharma M; Chaudhary U
Infect Disord Drug Targets; 2015; 15(3):196-201. PubMed ID: 26374327
[TBL] [Abstract][Full Text] [Related]
9. Emergence of fosfomycin resistance among isolates of Escherichia coli harboring extended-spectrum and AmpC β-lactamases.
Bahramian A; Eslami G; Hashemi A; Tabibi A; Heidary M
Acta Microbiol Immunol Hung; 2018 Mar; 65(1):15-25. PubMed ID: 29137487
[TBL] [Abstract][Full Text] [Related]
10. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance.
Shah C; Baral R; Bartaula B; Shrestha LB
BMC Microbiol; 2019 Sep; 19(1):204. PubMed ID: 31477018
[TBL] [Abstract][Full Text] [Related]
11. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance and plasmid profile of uropathogenic Escherichia coli among urinary tract infection patients in Addis Abeba.
Regasa Dadi B; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
J Infect Dev Ctries; 2018 Aug; 12(8):608-615. PubMed ID: 31958322
[TBL] [Abstract][Full Text] [Related]
13. Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.
Harwalkar A; Gupta S; Rao A; Srinivasa H
J Infect Public Health; 2014; 7(5):413-9. PubMed ID: 24861644
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.
Ramírez-Castillo FY; Moreno-Flores AC; Avelar-González FJ; Márquez-Díaz F; Harel J; Guerrero-Barrera AL
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):34. PubMed ID: 30041652
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131.
de Souza da-Silva AP; de Sousa VS; de Araújo Longo LG; Caldera S; Baltazar ICL; Bonelli RR; Santoro-Lopes G; Riley LW; Moreira BM
Infect Genet Evol; 2020 Nov; 85():104452. PubMed ID: 32634601
[TBL] [Abstract][Full Text] [Related]
16. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
[TBL] [Abstract][Full Text] [Related]
17. Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection.
González MJ; Da Cunda P; Notejane M; Zunino P; Scavone P; Robino L
Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31062019
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species and uspA overexpession: an alternative bacterial response toward selection and maintenance of multidrug resistance in clinical isolates of uropathogenic E. coli.
Bandyopadhyay D; Mukherjee M
Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1753-1760. PubMed ID: 32399681
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan.
Tseng SP; Wang SF; Kuo CY; Huang JW; Hung WC; Ke GM; Lu PL
PLoS One; 2015; 10(8):e0135864. PubMed ID: 26280832
[TBL] [Abstract][Full Text] [Related]
20. Distribution of genes encoding adhesins and biofilm formation capacity among Uropathogenic
Kadry AA; Al-Kashef NM; El-Ganiny AM
Afr Health Sci; 2020 Mar; 20(1):238-247. PubMed ID: 33402912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
